Trial Tests Atezolizumab Plus Capecitabine in Triple-Negative Breast Cancer
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative ...
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine